Information Journal Paper
APA:
Copy. (2018). Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. NEUROTHERAPEUTICS, 15(2), 430-438. SID. https://sid.ir/paper/740905/en
Vancouver:
Copy. Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. NEUROTHERAPEUTICS[Internet]. 2018;15(2):430-438. Available from: https://sid.ir/paper/740905/en
IEEE:
Copy, “Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial,” NEUROTHERAPEUTICS, vol. 15, no. 2, pp. 430–438, 2018, [Online]. Available: https://sid.ir/paper/740905/en